IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,185,839 | +118.2% | 200,746 | +159.5% | 0.08% | +110.5% |
| Q2 2023 | $1,459,915 | +186.3% | 77,367 | -27.8% | 0.04% | +58.3% |
| Q1 2022 | $510,000 | -37.0% | 107,126 | -1.7% | 0.02% | -52.0% |
| Q4 2021 | $809,000 | +517.6% | 108,979 | +373.2% | 0.05% | +400.0% |
| Q3 2021 | $131,000 | -37.3% | 23,032 | -27.4% | 0.01% | -44.4% |
| Q2 2021 | $209,000 | -34.9% | 31,703 | -20.0% | 0.02% | -37.9% |
| Q1 2021 | $321,000 | -40.6% | 39,627 | -52.7% | 0.03% | -49.1% |
| Q4 2020 | $540,000 | -84.5% | 83,717 | -74.7% | 0.06% | -76.5% |
| Q1 2018 | $3,484,000 | +376.6% | 331,215 | +190.6% | 0.24% | +203.8% |
| Q4 2017 | $731,000 | -8.6% | 113,971 | +8.9% | 0.08% | -60.4% |
| Q3 2017 | $800,000 | +244.8% | 104,633 | +220.0% | 0.20% | +215.6% |
| Q2 2017 | $232,000 | +31.1% | 32,697 | -43.1% | 0.06% | +178.3% |
| Q2 2016 | $177,000 | -75.2% | 57,444 | -22.7% | 0.02% | -62.3% |
| Q3 2015 | $713,000 | -62.5% | 74,300 | -43.8% | 0.06% | -71.4% |
| Q2 2015 | $1,899,000 | – | 132,100 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |